T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells
Crossref DOI link: https://doi.org/10.1186/s13045-017-0488-x
Published Online: 2017-06-08
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mihara, Keichiro
Yoshida, Tetsumi
Takei, Yoshifumi
Sasaki, Naomi
Takihara, Yoshihiro
Kuroda, Junya
Ichinohe, Tatsuo
Funding for this research was provided by:
Ministry of Health, Labour and Welfare